Chimeric antigen receptor-based immunotherapy in breast cancer: Recent progress in China. Yu T, Lu Y, Fang J, Jiang X, et al. Cancer 2023 Nov 11. doi: 10.1002/cncr.35096.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yu T, Lu Y, Fang J, Jiang X, et al. Chimeric antigen receptor-based immunotherapy in breast cancer: Recent progress in China. Cancer 2023 Nov 11. doi: 10.1002/cncr.35096.
PMID: 37950749